Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) should contact Levi & Korsinsky about pending Class Action - REGN
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who lost money are encouraged to contact the law firm.
February 27, 2025 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. by Levi & Korsinsky, LLP. This legal action could impact investor sentiment and the company's stock price.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and damage to reputation. Investors may react by selling shares, leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100